BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 845440)

  • 1. Resistance to murine leukemia in mice receiving simultaneous injections of syngeneic hybrid and parental neoplastic cells.
    Liang W; Cohen EP
    J Immunol; 1977 Mar; 118(3):903-8. PubMed ID: 845440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W; Cohen EP
    J Immunol; 1976 Mar; 116(3):623-6. PubMed ID: 1254947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine leukemia cell hybrids: the quantity of TL antigens expressed by parental and hybrid cells fails to correlate with their sensitivity to TL antibody and complement.
    Cohen EP; Liang W
    J Supramol Struct; 1978; 9(4):525-36. PubMed ID: 750764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of the immunoprotective effects of leukemia X fibroblast hybrid cells toward leukemia in histocompatible mice.
    Garber SL; Cohen EP; Chang I
    Leuk Res; 1984; 8(2):255-66. PubMed ID: 6717066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent control of the expression of several membrane-associated antigens of murine leukemia cells: metabolism and response to specific antiserum.
    Cohen EP; Liang W
    Prog Clin Biol Res; 1976; 9():89-99. PubMed ID: 1030806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement sensitivity of somatic hybrids of a complement-resistant murine leukemia cell line.
    Liang W; Cohen EP
    J Natl Cancer Inst; 1975 Aug; 55(2):309-17. PubMed ID: 51086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface antigens of immunoprotective leukaemia x fibroblast hybrid cells which have lost malignant properties in histocompatible mice differ from the malignant parental cells.
    Slomski R; Wang DR; Cohen EP
    Immunology; 1984 Jun; 52(2):281-90. PubMed ID: 6376336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprotective capability of somatic hybrid cells in comparison with parental tumor cells maintained in vitro.
    Mizushima Y; Cohen EP
    Tohoku J Exp Med; 1985 Apr; 145(4):447-53. PubMed ID: 4024076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to murine leukemia induced in susceptible mice by transfected mouse fibroblasts.
    Slomski R; Hagen K; Kim YS; Cohen EP
    Leukemia; 1987 Mar; 1(3):213-9. PubMed ID: 2823015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia X fibroblast hybrid cells prolong the lives of leukemic mice.
    Wang DR; Slomski R; Cohen EP
    Eur J Cancer Clin Oncol; 1985 May; 21(5):637-43. PubMed ID: 3159580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukaemia x fibroblast hybrid cells augment the antibody response to sheep red blood cells in inbred mice.
    Cohen EP; Hagen K
    Immunology; 1985 Dec; 56(4):615-23. PubMed ID: 3908292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation of membrane-associated determinants is an outgrowth of their metabolism.
    Cohen EP
    Prog Clin Biol Res; 1980; 42():145-68. PubMed ID: 6248890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of specific cellular immunity toward murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W; Cohen EP
    J Immunol; 1977 Sep; 119(3):1054-60. PubMed ID: 302270
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.